logo
Select company
Select metric
$ 1.73MCapital Expenditure
VS
Market
66
Sector
37
Industry
20
History
33
$ 3.01Close
$ 1.47 - $ 14.47 52-Week Range
Ticker Information

Ticker

ARTV

Company Name

ARTIVA BIOTHERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ARTIVA BIOTHERAPEUTICS INC - Capital Expenditure Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ARTV - CapEx Historical data
DateCapital Expenditure
6/30/2025$ 1.73M
3/31/2025$ 1.14M
12/31/2024$ 642K
12/31/2023$ 3.26M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ARTIVA BIOTHERAPEUTICS INC's latest trailing twelve months (TTM) CapEx stands at $ 3.26M.
  • Over the past 5 years, ARTIVA BIOTHERAPEUTICS INC's average CapEx has been $ 1.69M.
  • The median CapEx for ARTIVA BIOTHERAPEUTICS INC during this period was $ 1.43M
  • ARTIVA BIOTHERAPEUTICS INC reached its highest CapEx over the past 5 years at $ 3.26M.
  • The lowest CapEx recorded by ARTIVA BIOTHERAPEUTICS INC in the same timeframe $ 642K

Definition of Capital Expenditure

[Cash Flow Statement] CapEX, also know as capital expenditures, is a component of investing cash flow [NCFI] that refers to funds that are used to acquire, improve or maintain long-term assets [AssestsNC] of the company. Capital expense may include the purchase of new equipment, machinery, buildings or warehouses, furniture, software or intangibles such as intellectual property.

ARTV - Capital Expenditure, Last 5 years

$ 642K

Minimum

Dec 31, 2024

$ 3.26M

Maximum

Dec 31, 2023

$ 1.69M

Average

$ 1.43M

Median

CapEx Benchmark Analysis

The chart above depicts the distribution of CapEx for companies in the Total Stock Market. The average CapEx of the companies is $ 9.66M with a standard deviation of $ 15.86M.
The following table provides additional summary stats:
CapEx in the Market:
filtered constituents2.92K
min$ -41.06M
max$ 63.78M
average$ 9.66M
median$ 1.92M
std$ 15.86M